{"id":"NCT02504645","sponsor":"ImmuPharma","briefTitle":"A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus","officialTitle":"A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03","primaryCompletion":"2018-01","completion":"2018-01","firstPosted":"2015-07-22","resultsPosted":"2019-04-11","lastUpdate":"2019-04-11"},"enrollment":202,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lupus Erythematosus, Systemic"],"interventions":[{"type":"DRUG","name":"IPP-201101","otherNames":["Lupuzor, regiremod"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"OTHER","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"IPP-201101 200-mcg plus SOC","type":"ACTIVE_COMPARATOR"},{"label":"PLACEBO plus SOC","type":"PLACEBO_COMPARATOR"}],"summary":"This current Phase 3 study will evaluate the efficacy and safety of administration of subcutaneous (sc) IPP-201101 in patients with active SLE.","primaryOutcome":{"measure":"Assessment of Systemic Lupus Erythematosus Responder Index (SRI) at Week 52","timeFrame":"At week 52","effectByArm":[{"arm":"IPP-201101 200-mcg Plus SOC","deltaMin":52.5,"sd":null},{"arm":"PLACEBO Plus SOC","deltaMin":44.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2631"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":21},"locations":{"siteCount":30,"countries":["United States","Czechia","France","Germany","Hungary","Mauritius","Poland","Puerto Rico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":101},"commonTop":["Upper respiratory tract infection","Urinary tract infection","Headache","Arthritis","Alopecia"]}}